我院住院患者雾化吸入用药情况调查

Investigation on Use Drug of Atomization Inhalation in Inpatients in Our Hospital

目的 :了解我院住院患者雾化吸入用药情况,为规范我院雾化吸入用药提供依据。方法 :利用医院信息系统(HIS)采集我院2017年1月1日-5月31日雾化吸入用药的医嘱信息并生成统计表,再运用Excel电子表格对各种雾化吸入用药信息进行筛选统计。结果 :住院患者雾化吸入用药共计4 655人次,涉及临床科室17个,药品品种14种:化学药品12种、中药注射剂2种;雾化剂型3种,非雾化剂型11种。雾化吸入用药人次排名前三的科室分别是:儿科、呼吸科、心内科,人次排名前三的药品分别是:吸入用硫酸沙丁胺醇溶液、吸入用布地奈德混悬液、注射用糜蛋白酶。结论 :我院雾化吸入用药的超说明书用药情况普遍,应加强雾化吸入合理用药综合管理。

Objective:To understand the situation of atomization inhalation in inpatients in our hospital to provide a basis for standardizing the atomization inhalation of drugs in our hospital. Methods:The information of doctor's advice for atomization inhalation in our hospital from January 1, 2017 to May 31, 2017 was collected by using hospital information system(HIS) and then statistical tables were generated. Excel spreadsheets were used for screening and statistics of various inhalation medication information. Results:The total number of atomization inhalation in inpatients was 4,655, involving 17 clinical departments, 14 drug varieties: 12 chemical drugs, 2 traditional Chinese medicine injections; 3 atomization dosage forms and 11 non-atomization dosage forms. The top three departments of atomization inhalation were: pediatrics, respiratory department and department of cardiology, and the top three drugs used were salbutamol sulfate solution for inhalation, budesonide suspension for inhalation, chymotrypsin for injection. Conclusion:The situation of off-labeled drug use in our hospital is universal in atomization inhalation, so the comprehensive management of rational drug use should be strengthened.